| 000 | 01661 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516111949.0 | ||
| 264 | 0 | _c20130107 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1083-351X | ||
| 024 | 7 |
_a10.1074/jbc.M112.382069 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKönig, Matthias | |
| 245 | 0 | 0 |
_aKinetic modeling of human hepatic glucose metabolism in type 2 diabetes mellitus predicts higher risk of hypoglycemic events in rigorous insulin therapy. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cOct 2012 |
||
| 300 |
_a36978-89 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 | _aBlood Glucose |
| 650 | 0 | 4 | _aCarbohydrate Metabolism |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aEpinephrine _xblood |
| 650 | 0 | 4 |
_aGlucagon _xblood |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aGlycogen _xmetabolism |
| 650 | 0 | 4 |
_aHepatocytes _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xblood |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aInsulin _xadverse effects |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLiver _xcytology |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aPostprandial Period |
| 650 | 0 | 4 | _aProtein Processing, Post-Translational |
| 700 | 1 | _aHolzhütter, Hermann-Georg | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 287 _gno. 44 _gp. 36978-89 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M112.382069 _zAvailable from publisher's website |
| 999 |
_c22104284 _d22104284 |
||